Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Sep 21, 2023

BUY
$58.92 - $84.67 $883,800 - $1.27 Million
15,000 Added 300.0%
20,000 $1.24 Million
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $883,800 - $1.27 Million
15,000 Added 300.0%
20,000 $0
Q1 2022

Sep 21, 2023

SELL
$86.42 - $109.81 $5.14 Million - $6.53 Million
-59,500 Reduced 92.25%
5,000 $526,000
Q1 2022

May 16, 2022

SELL
$86.42 - $109.81 $5.14 Million - $6.53 Million
-59,500 Reduced 92.25%
5,000 $0
Q4 2021

Sep 21, 2023

BUY
$98.56 - $119.91 $906,752 - $1.1 Million
9,200 Added 16.64%
64,500 $6.95 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $906,752 - $1.1 Million
9,200 Added 16.64%
64,500 $0
Q3 2021

Sep 21, 2023

SELL
$91.91 - $110.37 $6.35 Million - $7.63 Million
-69,100 Reduced 55.55%
55,300 $6.06 Million
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $6.35 Million - $7.63 Million
-69,100 Reduced 55.55%
55,300 $6.06 Million
Q1 2021

Sep 21, 2023

BUY
$71.83 - $95.48 $8.62 Million - $11.5 Million
120,000 Added 2727.27%
124,400 $11.4 Million
Q1 2021

May 14, 2021

BUY
$71.83 - $95.48 $8.62 Million - $11.5 Million
120,000 Added 2727.27%
124,400 $0
Q4 2020

Sep 21, 2023

SELL
$67.0 - $84.39 $1.05 Million - $1.32 Million
-15,600 Reduced 78.0%
4,400 $321,000
Q4 2020

Feb 16, 2021

SELL
$67.0 - $84.39 $1.27 Million - $1.59 Million
-18,900 Reduced 81.12%
4,400 $322,000
Q3 2020

Nov 13, 2020

BUY
$55.23 - $79.93 $1.18 Million - $1.7 Million
21,300 Added 1065.0%
23,300 $1.81 Million
Q2 2020

Aug 14, 2020

BUY
$30.2 - $56.98 $60,400 - $113,960
2,000 New
2,000 $0

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.